GSK reports net profit increase of 7% in first quarter
Pharmaceutical group GlaxoSmithKline reports first-quarter profit growth driven by its medications.
Published 10sem1 sourceNotableupdated 10sem
Lire en français
≈ 16s
The fact
The increase is driven by sustained demand for its main treatments.
GSK consolidates its position in the life sciences sector.
Observed impact
Hausse de 7 % des bénéfices nets au T1
Renforcement de la position concurrentielle dans les sciences de la vie